ANEW 202
Alternative Names: ANEW-202Latest Information Update: 24 Sep 2024
Price :
$50 *
At a glance
- Originator ANEW MEDICAL
- Developer Klotho Neurosciences
- Class Gene therapies
- Mechanism of Action Gene transference; Klotho protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alzheimer's disease; Amyotrophic lateral sclerosis; Parkinson's disease
Most Recent Events
- 17 Sep 2024 ANEW MEDICAL is now called Klotho Neurosciences
- 17 Sep 2024 ANEW MEDICAL plans a meeting with the US FDA to discuss the IND and for the potential commencement of clinical trials in Amyotrophic lateral sclerosis
- 17 Sep 2024 ANEW MEDICAL plans to initiate clinical trials in Amyotrophic lateral sclerosis